Insulin-replacement medications - revenues 2010
Revenues from leading insulin-replacement medications in 2010 (in billion euros)
This statistic shows global revenues from top insulin-replacement medications in 2010. The medication Humalin brought in 0.78 billion euros in revenue worldwide.
Revenues from leading insulin-replacement medications in 2010 (in billion euros)
Source
More information
Statistics on "Top pharmaceutical drugs"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Revenue of top growing private specialty pharmacies in U.S. 2017
- Italy: number of biotech drugs marketed 2016-2017, by type
- Usage rate of top drug classes prescribed to seniors in Canada 2016, by location
- Usage rate of top drug classes prescribed to seniors in Canada 2016, by age
- Number of injection drugs that had shortages in Canada in 2013-2016, by company
- Usage rate of top drug classes prescribed to seniors in Canada 2016, by gender
- Leading MS pharmaceutical drugs in the U.S. by revenue 2013
- Top drug classes prescribed to seniors living in LTC in Canada 2016, by rate of use
- Top drug classes prescribed to seniors living in LTC Canada 2016, by chronic use rate
- Price change of branded drugs U.S. 2011-2017
- Top drug classes prescribed to seniors in Canada 2016, by rate of use
- Biotech vs. Web 2.0 share of total U.S. venture investment 2005-2010
- Contributions share to R&D for transformative drugs of past 25 years as of 2016
- Pharma and biotech - average p/e ratios in 2005 and 2010
- Canadian biotechnology - number of companies 2012-2014
- U.S. insulin market distribution: leading companies 2011
Statistics on "Top pharmaceutical drugs"
Related topics
About Statista
